Clinical Trials
14 trialsNCT07209189 2026-04-23
(NeoScorch HN)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT01898494 2026-04-01
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT00867464 2026-03-03
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
National Cancer Institute (NCI)
Active not recruiting
NCT07418034 2026-02-18
SAVED
University of Maryland, Baltimore
Phase 2 Not yet recruiting
NCT07033091 2026-02-13
Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
The Institute of Molecular and Translational Medicine, Czech Republic
Phase NA Recruiting
NCT05774561 2026-02-12
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
The Institute of Molecular and Translational Medicine, Czech Republic
Recruiting
NCT01932697 2026-02-10
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Mayo Clinic
Phase 2 Completed
NCT01302834 2026-01-12
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT04124198 2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA Active not recruiting
NCT06362421 2025-07-31
Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
Wake Forest University Health Sciences
Withdrawn
NCT05592626 2025-07-09
START-001
Marengo Therapeutics, Inc.
Phase 1/2 Recruiting
NCT07036211 2025-06-25
TREVINO
Tampere University Hospital
Not yet recruiting
NCT05388773 2025-06-19
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
University of Pittsburgh
Phase 2 Recruiting
NCT04965792 2025-06-17
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Dana-Farber Cancer Institute
Active not recruiting